{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:37:47Z","timestamp":1787017067578,"version":"build-2736575974"},"reference-count":33,"publisher":"BMJ","issue":"6","license":[{"start":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T00:00:00Z","timestamp":1655251200000},"content-version":"unspecified","delay-in-days":14,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Ministry of Health Czech Republic","award":["NU21-02-00388"],"award-info":[{"award-number":["NU21-02-00388"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2022,5,15]]},"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Atrial fibrillation (AF), with a prevalence of 2%, is the most common cardiac arrhythmia. Catheter ablation (CA) has been documented to be superior to treatment by antiarrhythmic drugs (AADs) in terms of sinus rhythm maintenance. However, in obese patients, substantial weight loss was also associated with AF reduction. So far, no study has compared the modern non-invasive (AADs combined with risk factor modification (RFM)) approach with modern invasive (CA) treatment. The aim of the trial is to compare the efficacy of modern invasive (CA) and non-invasive (AADs with risk factor management) treatment of AF.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>The trial will be a prospective, multicentre, randomised non-inferiority trial. Patients with symptomatic AF and a body mass index &gt;30\u2009will be enrolled and randomised to the CA or RFM arm (RFM+AAD) in a 1:1 ratio. In the CA arm, pulmonary vein isolation (in combination with additional lesion sets in non-paroxysmal patients) will be performed. For patients in the RFM+AAD\u2009arm, the aim will be a 10% weight loss over 6\u201312 months, increased physical fitness and a reduction in alcohol consumption. The primary endpoint will be an episode of AF or regular atrial tachycardia lasting &gt;30\u2009s. The secondary endpoints include AF burden, clinical endpoints associated with AF reoccurrence, changes in the quality of life assessed using dedicated questionnaires, changes in cardiorespiratory fitness and metabolic endpoints. An AF freedom of 65% in the RFM+AAD\u2009and of 60% in the CA is expected; therefore, 202 patients will be enrolled to achieve the non-inferiority with 80% power, 5% one-sided alpha and a non-inferiority margin of 12%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>The PRAGUE-25 trial will determine if modern non-invasive AF treatment strategies are non-inferior to CA. The study was approved by the Ethics Committee of the University Hospital Kralovske Vinohrady. Results of the study will be disseminated on scientific conferences and in peer-reviewed scientific journals. After the end of follow-up, data will be available upon request to principal investigator.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      ClinicalTrials.gov Registry (\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT04011800\">NCT04011800<\/jats:ext-link>\n                      ).\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2021-056522","type":"journal-article","created":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T13:05:11Z","timestamp":1655298311000},"page":"e056522","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["Catheter ablation versus antiarrhythmic drugs with risk factor modification for treatment of atrial fibrillation: a protocol of a randomised controlled trial (PRAGUE-25 trial)"],"prefix":"10.1136","volume":"12","clinical-trial-number":[{"clinical-trial-number":"nct04011800","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct04011800","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0482-4448","authenticated-orcid":false,"given":"Pavel","family":"Osmancik","sequence":"first","affiliation":[{"name":"Department of Cardiology, Kralovske Vinohrady University Hospital, Prague, Czech Republic"},{"name":"Department of Cardiology, 3rd Faculty of Medicine, Charles University, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0160t\u011bp\u00e1n","family":"Havr\u00e1nek","sequence":"additional","affiliation":[{"name":"Cardiocenter, Second Internal Clinic-Cardiology and Angiology, Charles University, General Faculty Hospital, Prague, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Bulkov\u00e1","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Hospital Brno, Brno, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Chovan\u010d\u00edk","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Charles University, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom\u00e1\u0161","family":"Roub\u00ed\u010dek","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Regional Hospital Liberec, Liberec, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalibor","family":"He\u0159man","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kralovske Vinohrady University Hospital, Prague, Czech Republic"},{"name":"Department of Cardiology, 3rd Faculty of Medicine, Charles University, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuzana","family":"\u010carn\u00e1","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kralovske Vinohrady University Hospital, Prague, Czech Republic"},{"name":"Department of Cardiology, 3rd Faculty of Medicine, Charles University, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladim\u00edr","family":"Tuka","sequence":"additional","affiliation":[{"name":"Cardiocenter, Second Internal Clinic-Cardiology and Angiology, Charles University, General Faculty Hospital, Prague, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Matoulek","sequence":"additional","affiliation":[{"name":"Cardiocenter, Second Internal Clinic-Cardiology and Angiology, Charles University, General Faculty Hospital, Prague, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Fiala","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Hospital Brno, Brno, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otakar","family":"Jiravsk\u00fd","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Charles University, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Stregl-Hruskova","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Regional Hospital Liberec, Liberec, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Lati\u0148\u00e1k","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Regional Hospital Liberec, Liberec, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji\u0159ina","family":"Kotryov\u00e1","sequence":"additional","affiliation":[{"name":"Masaryk University, Brno, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji\u0159\u00ed","family":"Jarkovsk\u00fd","sequence":"additional","affiliation":[{"name":"Institute of Biostatistics and Analyses, Brno University of Technology, Brno, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,6,15]]},"reference":[{"key":"2025121221364243000_12.6.e056522.1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000140263.20897.42"},{"key":"2025121221364243000_12.6.e056522.2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.005119"},{"key":"2025121221364243000_12.6.e056522.3","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.109.856633"},{"key":"2025121221364243000_12.6.e056522.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1707855"},{"key":"2025121221364243000_12.6.e056522.5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.0693"},{"key":"2025121221364243000_12.6.e056522.6","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1056\/NEJMoa2029554","article-title":"Cryoballoon ablation as initial therapy for atrial fibrillation","volume":"384","author":"Wazni","year":"2021","journal-title":"N Engl J Med"},{"key":"2025121221364243000_12.6.e056522.7","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJMoa2029980","article-title":"Cryoablation or drug therapy for initial treatment of atrial fibrillation","volume":"384","author":"Andrade","year":"2021","journal-title":"N Engl J Med"},{"key":"2025121221364243000_12.6.e056522.8","article-title":"Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation","author":"Lafuente-Lafuente","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"2025121221364243000_12.6.e056522.9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2019422"},{"key":"2025121221364243000_12.6.e056522.10","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euq450"},{"key":"2025121221364243000_12.6.e056522.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2007.07.020"},{"key":"2025121221364243000_12.6.e056522.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.09.002"},{"key":"2025121221364243000_12.6.e056522.13","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1093\/europace\/euy117","article-title":"Prevention and regressive effect of weight-loss and risk factor modification on atrial fibrillation: the REVERSE-AF study","volume":"20","author":"Middeldorp","year":"2018","journal-title":"Europace"},{"key":"2025121221364243000_12.6.e056522.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacep.2015.04.004"},{"key":"2025121221364243000_12.6.e056522.15","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.830042"},{"key":"2025121221364243000_12.6.e056522.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2006.08.060"},{"key":"2025121221364243000_12.6.e056522.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.08.641"},{"key":"2025121221364243000_12.6.e056522.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.09.028"},{"key":"2025121221364243000_12.6.e056522.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.03.002"},{"key":"2025121221364243000_12.6.e056522.20","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.018220"},{"key":"2025121221364243000_12.6.e056522.21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1817591"},{"key":"2025121221364243000_12.6.e056522.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.03.071"},{"key":"2025121221364243000_12.6.e056522.23","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.acvd.2018.11.011","article-title":"Epicardial fat thickness predicts atrial fibrillation recurrence after a first pulmonary vein isolation procedure using a second-generation cryoballoon","volume":"112","author":"Mirolo","year":"2019","journal-title":"Arch Cardiovasc Dis"},{"key":"2025121221364243000_12.6.e056522.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.07.065"},{"key":"2025121221364243000_12.6.e056522.25","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.114.001479"},{"key":"2025121221364243000_12.6.e056522.26","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.113.02419"},{"key":"2025121221364243000_12.6.e056522.27","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.clnesp.2018.08.007","article-title":"Weight loss is a critical factor to reduce inflammation","volume":"28","author":"Bianchi","year":"2018","journal-title":"Clin Nutr ESPEN"},{"key":"2025121221364243000_12.6.e056522.28","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/europace\/euw335","article-title":"Association of pre-ablation level of potential blood markers with atrial fibrillation recurrence after catheter ablation: a meta-analysis","volume":"19","author":"Jiang","year":"2017","journal-title":"Europace"},{"key":"2025121221364243000_12.6.e056522.29","doi-asserted-by":"publisher","DOI":"10.1007\/s10840-013-9867-6"},{"key":"2025121221364243000_12.6.e056522.30","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijcard.2019.02.054","article-title":"Short and long-term changes in platelet and inflammatory biomarkers after cryoballoon and radiofrequency ablation","volume":"285","author":"Bin Waleed","year":"2019","journal-title":"Int J Cardiol"},{"key":"2025121221364243000_12.6.e056522.31","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa605"},{"key":"2025121221364243000_12.6.e056522.32","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.108.824789"},{"key":"2025121221364243000_12.6.e056522.33","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(20)33732-3"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2021-056522","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T05:36:48Z","timestamp":1765604208000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2021-056522"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":33,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,6,15]]},"published-print":{"date-parts":[[2022,6]]}},"alternative-id":["10.1136\/bmjopen-2021-056522"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2021-056522","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6]]}}}